der Kinderbetreuung oder Vergünstigungen für Sport und Gesundheit. J&J Schweiz verfügt über eine solid aufgestellte Pensionskasse. Für J...&J zu arbeiten, kann grundsätzlich alles verändern. Auch SIE! Sind Sie bereit, Verantwortung zu übernehmen...
Kultur und Sport suchen wir per 1.5.2025 am Standort Solothurn eine/-n Verantwortliche/-n Jugendausbildung Jugend+Sport (J...+S)/Administration, 80%. Ihre Verantwortung Sie sind mitverantwortlich für die Jugendausbildung im Rahmen von Jugend+Sport (J...
Innovative Medicine (J&J IM) Supply Chain organization and is currently recruiting for a Junior Local Quality Owner I (f/m... Owners and the QA oversight of a selected Portfolio of (Combination-) Products manufactured at the J&J IM Schaffhausen site...
Innovative Medicine (J&J IM) Supply Chain organization and is currently recruiting for a 2 x Local Quality Owner Launch & Grow... of a selected Portfolio of (Combination-) Products for parenteral New Product Introductions (NPI) manufactured at the J&J...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »